The ongoing quest for innovation is the cornerstone of Onxeo’s performance.
Onxeo develops innovative products in the field of cancer and its associated pathologies aimed at fighting resistance and improving patient care, especially in orphan diseases. These new therapeutic approaches aim to provide answers where conventional treatments face limits of resistance and tolerance. They thus seek to improve the care of patients suffering from severe diseases and who have, in most cases, very few therapeutic alternatives.
Innovation, constant development of our knowledge and responsiveness are essential elements of this approach to excellence and a pledge of our performance and our sustainability. Within our principle of continuous improvement of our working methods, we also strive to develop the skills and expertise of our employees.
The very best solutions are derived from teamwork. Meaningful long-term relationships, mutual respect and sharing of knowledge and experience contribute every day to the realisation of this essential Onxeo’s value.
We are committed to providing clear and accurate information on projects, news and issues challenging Onxeo. Our goal is to enable all Onxeo’s partners to assess Company performance and evaluate its management.